Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response.
about
A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in CancerGlycoproteomic analysis of seven major allergenic proteins reveals novel post-translational modifications.Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles.Glycosyltransferases as Markers for Early Tumorigenesis.Tumor-Associated Glycans and Immune SurveillanceMGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic NephropathyMucins help to avoid alloreactivity at the maternal fetal interface.Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.Biomarker discovery of nasopharyngeal carcinoma by proteomics.GalNAc-T4 putatively modulates the estrogen regulatory network through FOXA1 glycosylation in human breast cancer cells.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.Glycan-mediated modification of the immune response.Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer.Oncogenic Epstein-Barr virus recruits Nm23-H1 to regulate chromatin modifiers.Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.Crystal structures of H-2Db in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and immunogenicity.De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide.An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides.The effect of acylation with fatty acids and other modifications on HLA class II:peptide binding and T cell stimulation for three model peptides.
P2860
Q26751472-CE345B5D-B7F0-4D44-A1B5-4B90F23193D9Q34884157-9B02355F-7B9C-4CA4-8BD9-3CA85D05E2CEQ35162645-812664A3-BD88-40CE-96D8-F90F703E7B67Q35802482-BDEC506C-DC94-431B-A134-355B604E9A95Q35890610-07036AD5-AA6F-493A-B607-46D311DC8BB8Q36413436-4EA5A92A-9D5E-4C74-894C-8581D9AD1700Q36889708-91716943-8EEE-41C7-B3C9-E714DA2F140DQ36995323-19FEA198-DE65-4C8A-B6F0-CF98B3953183Q37065966-AEA97A8A-D980-4C79-AEB5-596F8072DAF1Q37660331-C7D34D0A-3AEB-43C6-92C3-EA1D289AF499Q38194579-D565E69E-AB83-4238-9883-9D1C4A7B9CB7Q38821749-2F73D92A-9137-4D0C-8F25-02A966FFE344Q39313889-2A28B6EF-E207-453B-8FF7-D4CA5C11FEE8Q40725344-31B79674-1861-44FF-8DEB-9D1FC5706F8FQ41636538-61FF947C-D191-4140-8723-358D2F2E2F3BQ45326277-ED73FCCE-9538-4FF5-BDA5-4ADF0BBF3DA3Q46091778-C8755C42-F801-4193-92AD-E68606536344Q47144276-AFFEF810-D1D7-48BE-B4E6-07D6AA034F7EQ47301558-3D61816E-CD0F-4378-8DDD-70AF54425182Q47626278-A68E7531-A2A9-44CF-BC2E-7E8C49D4CBCAQ52582442-152A8ECF-6A12-4BEA-846B-AB3BC19A3830Q55097162-5FBCA442-2481-4282-87EA-C84E7DD66DC0
P2860
Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cancer associated aberrant pro ...... rocessing and immune response.
@ast
Cancer associated aberrant pro ...... rocessing and immune response.
@en
Cancer associated aberrant pro ...... rocessing and immune response.
@nl
type
label
Cancer associated aberrant pro ...... rocessing and immune response.
@ast
Cancer associated aberrant pro ...... rocessing and immune response.
@en
Cancer associated aberrant pro ...... rocessing and immune response.
@nl
prefLabel
Cancer associated aberrant pro ...... rocessing and immune response.
@ast
Cancer associated aberrant pro ...... rocessing and immune response.
@en
Cancer associated aberrant pro ...... rocessing and immune response.
@nl
P2093
P2860
P50
P1433
P1476
Cancer associated aberrant pro ...... rocessing and immune response.
@en
P2093
Caroline B Madsen
Cecilie Petersen
Henrik Clausen
Kirstine Lavrsen
Søren Buus
P2860
P304
P356
10.1371/JOURNAL.PONE.0050139
P407
P577
2012-11-26T00:00:00Z